Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy

Hui K Gan; Antony W Burgess; Andrew HA Clayton; Andrew M Scott

Journal article

Targeting of a Conformationally Exposed, Tumor-Specific Epitope of EGFR as a Strategy for Cancer Therapy

Hui K Gan, Antony W Burgess, Andrew HA Clayton, Andrew M Scott

Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2012

DOI: 10.1158/0008-5472.CAN-11-3898

University of Melbourne Researchers

Antony Burgess Author Surgery - Royal Melbourne Hospital

Grants

Awarded by National Health and Medical Research Council

Awarded by Victorian Cancer Agency

Funding Acknowledgements

A.W. Burgess and A. M. Scott are inventors on mAb806 patents. A. M. Scott has received funding from the Ludwig Institute for Cancer Research and from Abbott Pharmaceuticals and has served as a consultant for Life Science Pharmaceuticals. No potential conflicts of interest were reported by the other authors.National Health and Medical Research Council (487922); Operational Infrastructure Support, Victorian Government; Victorian Cancer Agency grant (CRF10-16 to H.K. Gan).